Enzymatic regeneration of adenosine triphosphate cofactor by Marshall, D. L.
May 1974	 B74-10057 
o	
NASA TECH BRIEF 
Ames Research Center 
NASA Tech Briefs announce new technology derived from the U.S. space program. They are issued to encourage 
commercial application. Tech Briefs are available on a subscription basis from the National Technical Information 
Service, Springfield, Virginia 22151. Requests for individual copies or questions relating to the Tech Brief program may 
be directed to the Technology Utilization Office, NASA, Code KT, Washington, D.C. 20546. 




Recent advances in enzyme technology have pro-
vided a new class of catalysts which may be of great 
use in industrial processes. Current applications of 
the new technology are limited to simple enzyme 
processes, where the cost of the expended cofactor is 
of little concern; however, if more complex enzymatic 
reactions are to be given consideration as candidates 
for large-scale continuous processes, it is first neces-
sary to develop techniques for regenerating the ex-
pensive cofactors in order to reduce catalyst costs 
to acceptably low values. 
The solution: 
Regenerate adenosine triphosphate (ATP) from 
adenosine diphosphate (ADP) by an enzymatic pro-
cess which utilizes carbamyl phosphate as the phos-
phoryl donor. 
How it's done: 
The reaction between ADP and carbamyl phos-
phate to form ATP is catalyzed by carbamyl phos-
phokinase; the overall reaction may be represented 
essentially as:
carbamyl 
ADP + NH2CO2PO,H 
phosphokinase 
ATP + [NH,CO2H]. 
A novel feature of the process is the extremely simple 
means of forming the carbamyl phosphate donor in 
the reaction medium. 
The enzyme, carbamyl phosphokinase, is isolated 
from Streptococcus faecalis and partially purified. To 
permit its reuse, it is immobilized by attachment to 
porous glass: Porous glass, obtained as the alkyl-
amine derivative, is treated for 30 minutes with a 2-
percent aqueous solution of glutaraldehyde and then 
washed thoroughly to remove excess glutaraldehyde.
The derivatized glass is added to a solution of the 
enzyme, the mixture stirred gently for 2 hours, and 
then the enzyme—glass product is washed free of Un-
reacted enzyme. The activity of the immobilized en-
zyme is 200 to 250 units per gram of glass (1 unit = 
1 micromole of ATP formed per minute at room 
temperature). 
The conversion of ADP to ATP takes place in a 
medium which contains potassium cyanate and potas-
sium phospate. Under these conditions, carbamyl 
phosphate forms spontaneously at room temperature 
and is utilized before decomposition can occur. Thus, 
when phosphate is used as buffer in the enzymatic 
reactions, only cyanate need be added along with 
ADP to regenerate ATP. 
A small column containing 0.5 gram of the im-
mobilized enzyme product was operated continuously 
for a period of 14 days. The solution pumped through 
the column was formed continuously from two stock 
solutions, one containing ADP, magnesium ions, and 
phosphate, and the other containing cyanate. The 
stock solutions were maintained at ice temperature 
and brought together in a mixing coil prior to enter-
ing the enzyme column. The column effluent was 
monitored periodically for ATP concentration by an 
enzymatic assay method. During the 14-day period, 
the activity of the column decreased by about 16 
percent. 
Note: 
No additional documentation is available. Specific 
questions, however, may be directed to: 
Technology Utilization Officer 
Ames Research Center 
Moffett Field, California 94035 
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Patent status: 
NASA has decided not to apply for a patent. 
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